Cargando…
Case report: Two heterozygous pathogenic variants of CYP24A1: A novel cause of hypercalcemia and nephrocalcinosis in adulthood
BACKGROUND AND AIMS: Vitamin D 24-hydroxylase is an enzyme encoded by the CYP24A1 gene, which inhibits the activation of vitamin D to form inactive metabolites. More than 20 currently described pathogenic variants (usually biallelic) of this gene are responsible for idiopathic infantile hypercalcemi...
Autores principales: | Brunerova, Ludmila, Remes, Ondrej, Zoubkova, Veronika, Votypka, Pavel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871448/ https://www.ncbi.nlm.nih.gov/pubmed/36703897 http://dx.doi.org/10.3389/fmed.2022.1020096 |
Ejemplares similares
-
Severe Hypercalcemia Due to Primary Hyperparathyroidism and Heterozygous Pathogenic Variant of CYP24A1
por: Liu, Jannel, et al.
Publicado: (2023) -
Correction to “Severe Hypercalcemia Due to Primary Hyperparathyroidism and Heterozygous Pathogenic Variant of CYP24A1”
Publicado: (2023) -
Phenotype of Idiopathic Infantile Hypercalcemia Associated with the Heterozygous Pathogenic Variant of SLC34A1 and CYP24A1
por: Bizerea-Moga, Teofana Otilia, et al.
Publicado: (2023) -
Infantile Nephrocalcinosis Resulting From a Pathogenic CYP24A1 Mutation
por: Murphy, Joel D., et al.
Publicado: (2019) -
Three Sisters With Heterozygous Gene Variants of CYP24A1: Maternal Hypercalcemia, New-Onset Hypertension, and Neonatal Hypoglycemia
por: Hedberg, Fredric, et al.
Publicado: (2018)